Prescription Drugs
Filters
穆峰达/Mounjaro(替尔泊肽)2.5–10mg/0.5mL 多剂量注射笔 | 礼来中国 | GLT
穆峰达(Mounjaro)——礼来原研替尔泊肽,中国大陆四规格多剂量注射笔(2.5/5/7.5/10mg),用于 2 型糖尿病和体重管理
Ceritinib（Spexib）150mg*150粒 | 诺华印度原研 | GLT
诺华印度市场的塞瑞替尼（Spexib）150mg 胶囊，每多包装 150 粒，用于 ALK 阳性非小细胞肺癌——与全球销售的 Zykadia 为同一原研药。
Ceritinib (Zykadia) 150mg*10's | Novartis Switzerland Originator | GLT
Novartis Switzerland originator Zykadia (ceritinib) 150mg capsules, 10-capsule starter pack for ALK-positive NSCLC.
Sumeirui (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Nanjing Youke Pharmaceutical Co., Ltd. | GLT
Generic baricitinib (JAK1/JAK2 inhibitor) by Nanjing Youke Pharmaceutical Co., Ltd. (China-Mainland) — an affordable alternative...
Ceritinib (Noxalk) 150mg*90's | Natco India Generic | GLT
Noxalk — Natco Pharma India generic ceritinib 150mg, 90-capsule pack for ALK-positive NSCLC.
Tepmetko (Tepotinib) 225mg*60 | Merck KGaA Germany Originator | GLT
Merck KGaA Germany originator tepotinib 225mg — the first oral MET inhibitor for NSCLC
Vitrakvi (Larotrectinib) 100mg×60 Capsules | Bayer US NTRK Fusion | GLT
Vitrakvi — Bayer originator larotrectinib (Loxo Oncology), US pack 100mg×60-capsule bottle (NDC 71777-391-01) for NTRK...
维泰凯（拉罗替尼）100mg×56 胶囊 | 拜耳 中国 NTRK 融合 | GLT
维泰凯 Vitrakvi——拜耳原研拉罗替尼，100mg×56 粒装（国药准字 HJ20220033），用于 NTRK 融合阳性实体瘤，中国大陆。
PHOBRIGA (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT
Lao generic brigatinib by Pharma 2 Vientiane, affordable ALK+ NSCLC therapy
Saibriga (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT
Lao generic brigatinib by BioSpring, affordable ALK+ NSCLC therapy
Taihe 太禾 Emtricitabine/Tenofovir 200mg/300mg | Anhui Biochem Generic | GLT
NMPA-approved Anhui Biochem Taihe 太禾 emtricitabine 200mg + tenofovir disoproxil fumarate 300mg tablets, Chinese generic...
排序
- 推荐
- 价格由低到高
- 价格由高到底
- 最新
- 销量最高